Related Experiment Video
Updated: May 17, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Methamphetamine reduces human influenza A virus replication
Yun-Hsiang Chen1, Kuang-Lun Wu, Chia-Hsiang Chen
1Division of Mental Health and Addiction Medicine, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
Abstract:
Methamphetamine (meth) is a highly addictive psychostimulant that is among the most widely abused illicit drugs, with an estimated over 35 million users in the world. Several lines of evidence suggest that chronic meth abuse is a major factor for increased risk of infections with human immunodeficiency virus and possibly other pathogens, due to its immunosuppressive property. Influenza A virus infections frequently cause epidemics and pandemics of respiratory diseases among human populations. However, little is known about whether meth has the ability to enhance influenza A virus replication, thus increasing severity of influenza illness in meth abusers. Herein, we investigated the effects of meth on influenza A virus replication in human lung epithelial A549 cells. The cells were exposed to meth and infected with human influenza A/WSN/33 (H1N1) virus. The viral progenies were titrated by plaque assays, and the expression of viral proteins and cellular proteins involved in interferon responses was examined by Western blotting and immunofluorescence staining. We report the first evidence that meth significantly reduces, rather than increases, virus propagation and the susceptibility to influenza infection in the human lung epithelial cell line, consistent with a decrease in viral protein synthesis. These effects were apparently not caused by meth's effects on enhancing virus-induced interferon responses in the host cells, reducing viral biological activities, or reducing cell viability. Our results suggest that meth might not be a great risk factor for influenza A virus infection among meth abusers. Although the underlying mechanism responsible for the action of meth on attenuating virus replication requires further investigation, these findings prompt the study to examine whether other structurally similar compounds could be used as anti-influenza agents.
Insights
Methamphetamine (meth) use was found to decrease, not increase, influenza A virus replication in lung cells. This suggests meth may not be a significant risk factor for severe influenza illness in users.
Area of Science:
- Virology
- Immunology
- Pharmacology
Background:
- Methamphetamine (meth) is a widely abused psychostimulant linked to increased infection risk.
- Influenza A virus causes significant respiratory disease globally.
- The impact of meth on influenza A virus replication and severity is largely unknown.
Purpose of the Study:
- To investigate the effect of methamphetamine on influenza A virus replication in human lung cells.
- To determine if meth enhances or inhibits influenza A virus propagation and infection susceptibility.
Main Methods:
- Human lung epithelial A549 cells were exposed to methamphetamine.
- Cells were infected with human influenza A/WSN/33 (H1N1) virus.
- Viral replication was assessed via plaque assays; protein expression was analyzed using Western blotting and immunofluorescence.
Main Results:
- Methamphetamine significantly reduced influenza A virus propagation and infection susceptibility in lung cells.
- A decrease in viral protein synthesis was observed.
- Meth's effects were not attributed to enhanced interferon responses, reduced viral activity, or decreased cell viability.
Conclusions:
- Methamphetamine may not be a significant risk factor for influenza A virus infection severity in abusers.
- The mechanism of meth-induced attenuation of influenza replication requires further study.
- Findings suggest potential for structurally similar compounds as anti-influenza agents.
More Related Videos
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
09:39Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein
Published on: April 21, 2015
Related Concept Videos
Influenza
Inhibitors of Viral Protein Synthesis
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Viral Mutations
Leaky Scanning